Modeling the Impact of Higher Prescription Volumes on Net Drug Prices

With:
TBD
|
Funding:
Looking for support
Modeling the Impact of Higher Prescription Volumes on Net Drug Prices

If we eliminated out-of-pocket costs, more patients would be able to access the medications they need. Branded drug volumes would likely go up, but increased drug company margins would make it possible for PBMs to drive further price competition in competitive drug classes, mitigating the impact of eliminating OOP costs on overall societal spending. We plan to model these dynamics.

View all Research

Interested in getting in touch?

Contact a member of our staff

Feel free to reach out with questions, concerns, or comments.

Contact us